SCAI Statement on Thyroid Monitoring in Young Children Receiving Iodinated Contrast Media
SCAI believes that the current data is insufficient to warrant the course of action described within the recent Food and Drug Administration Drug Safety Communication and that further studies are needed to define at-risk groups accurately, clarify the risks of ICM exposure, and provide rational monitoring and treatment guidelines.
Nov 1st, 2021
Article
Oct 22nd, 2021
Article
SCAI Applauds Senate for Introduction of Prior Authorization Reform Legislation
Government Relations
As a member of the Regulatory Relief Coalition (RRC), SCAI is thrilled to support legislation introduced in the Senate this week, S. 3018, that mirrors H....
Oct 21st, 2021
Article
Oct 20th, 2021
Article
Medicare Cuts in Four Easy Pieces
Government Relations
An overview of proposed Medicare cuts to physician budgets and their impacts on health care
Oct 13th, 2021
Article
Oct 8th, 2021
Article
Oct 5th, 2021
Article
President's Message—October 2021
Clinical Practice
Government Relations
SCAI President, Dr. Tim Henry, MSCAI, is joined by the Co-Chairs of SCAI's Government Relations Committtee, Drs. Lyndon Box, FSCAI, and Joaquin Cigarroa, ...
Sep 29th, 2021
Article
Cardiovascular Disease: Talk to Your Patients About Screening
Clinical Practice
Government Relations
Sep 29th, 2021
Article
Medicare Fixes: If Not Now, When?
Government Relations
Contact your Representative and urge them to reform and stabilize health care provider payments.
Sep 29th, 2021
Article
Proposed Medicare Cuts Make PAD Awareness Month More Poignant
Clinical Practice
Government Relations
Peripheral